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Stem Cell Factor (SCF) initiates its multiple
cellular responses by binding to the ectodo-
main of KIT, resulting in tyrosine kinase activa-
tion. We describe the crystal structure of the
entire ectodomain of KIT before and after SCF
stimulation. The structures show that KIT
dimerization is driven by SCF binding whose
sole role is to bring two KIT molecules together.
Receptor dimerization is followed by conforma-
tional changes that enable lateral interactions
between membrane proximal Ig-like domains
D4 and D5 of two KIT molecules. Experiments
with cultured cells show that KIT activation is
compromised by point mutations in amino
acids critical for D4-D4 interaction. Moreover,
a variety of oncogenic mutations are mapped
to the D5-D5 interface. Since key hallmarks of
KIT structures, ligand-induced receptor dimer-
ization, and the critical residues in the D4-D4
interface, are conserved in other receptors, the
mechanism of KIT stimulation unveiled in this
report may apply for other receptor activation.
INTRODUCTION
Stem cell factor (SCF) is a cytokine that mediates its
diverse cellular responses by binding to and activating
the receptor tyrosine kinase (RTK) KIT (also known as
SCF receptor). KIT was initially discovered as an onco-
gene in a feline retrovirus that captured an activated and
truncated form of the surface receptor (Besmer et al.,
1986). SCF is encoded by the murine steel (SI) locus while
KIT is encoded by the dominant white spotting (W) locus in
the mouse (Copeland et al., 1990; Huang et al., 1990; Fla-
nagan and Leder, 1990; Tan et al., 1990; Bernstein et al.,
1990). SCF functions as a noncovalent homodimer, and
both membrane-anchored and soluble forms of SCF gen-erated by alternative RNA splicing and by proteolytic pro-
cessing have been described (reviewed in Ashman, 1999).
KIT is a member of the type III family of RTKs, which also
includes PDGF-receptor-a and b, CSF-1 receptor (also
known asM-CSF receptor or FMS), and the FLT3 receptor
(also known as FLK2) (reviewed in Ullrich and Schles-
singer, 1990; Blume-Jensen and Hunter, 2001). KIT is
composed of a glycosylated extracellular ligand-binding
domain (ectodomain) that is connected to a cytoplasmic
region by means of a single transmembrane (TM) domain
(reviewed in Schlessinger, 2000). The ectodomain of KIT
and other members of type III RTKs all contain five Ig-
like domains, in which the second and third membrane
distal domains were shown to play a role in ligand recog-
nition (reviewed in Ullrich and Schlessinger, 1990). Other
RTKs whose extracellular ligand-binding domains are
composed exclusively of multiple Ig-like repeats include
members of the VEGF receptor family (7 Ig-like), CCK4
receptor (7 Ig-like), and FGF receptors (3 Ig-like). The
cytoplasmic region of KIT contains a protein tyrosine
kinase (PTK) domain with a large kinase-insert region,
another hallmark of type III RTKs. Binding of SCF to KIT
leads to receptor dimerization, intermolecular autophos-
phorylation, and PTK activation. It was proposed that
the fourth Ig-like domain of KIT is responsible for KIT
dimerization in response to either monovalent or bivalent
SCF binding (Lev et al., 1992; Blechman et al., 1995).
However, other studies have demonstrated that ligand-
induced dimerization of KIT is driven by bivalent binding
of SCF (Philo et al., 1996; Lemmon et al., 1997).
Characterization of mice mutated at the Scf or Kit loci
has shown that SCF and KIT are required for development
of hematopoietic cells, melanocytes, germ cells, and
intestinal pacemaker cells (reviewed in Ashman, 1999).
In humans, loss-of-function mutations in KIT cause the
piebald trait that is characterized by depigmentation of
the ventral chest and abdomen, white fareflock of hair,
deafness, and constipation (Fleischman et al., 1991). A
variety of gain-of-function mutations in KIT were found in
different types of human cancers. Activating KIT muta-
tions were found in gastro-intestinal-stromal tumorsCell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc. 323
Figure 1. Crystal Structure of KIT Ectodomain
(A) Ribbon diagram (left) and surface representation (right) of KIT ectodomain monomer. Right panel shows a view following 90 rotation along the
vertical axis of the view shown in the left panel. D1 is colored in blue, D2 in green, D3 in yellow, D4 in orange, and D5 in pink; N and C termini are
labeled. Disulfide bonds in D1 and D5 are shown in ball-and-stick rendering with sulfur atoms colored in orange. Asparagine-linked carbohydrates
are shown in a stick model.
(B–E) Detailed views of D1-D2 (B), D2-D3 (C), D3-D4 (D), and D4-D5 (E) interfaces. Color coding is the same as in (A). Amino acids that participate in
domain-domain interactions are labeled and hydrogen bonds are drawn as dashed yellow lines. Secondary structure elements are designated
according to IgSF nomenclature.(GIST), acute myeloid leukemia (AML), and mast cell
leukemia (MCL), among other cancers. Mutations were
identified in the membrane-proximal Ig-like domain (D5)
(exons 8 and 9), in the juxtamembrane (JM) domain
(exon 11), and in the tyrosine kinase (PTK) domain (exon
17) (reviewed in Forbes et al., 2006). While there is good
evidence that the gain-of-function mutations in the JM
and the PTK domains lead to constitutive activation of
KIT, by relieving autoinhibitory constraints (Mol et al.,
2004), the molecular mechanism underlying the gain-of-
function mutations in D5 of the ectodomain is not
understood.
In this report we describe the crystal structures of the
entire ectodomain of KIT in both monomeric and SCF-
induced homodimeric (SCF-KIT 2:2 complex) forms. De-
tailed views of the unoccupied monomeric form at 3.0 A˚
resolution and SCF-induced homodimeric form at 3.5 A˚
resolution provide novel insights concerning the activation
mechanism of KIT and other RTKs.
RESULTS AND DISCUSSION
The entire ectodomain of KIT composed of five Ig-like do-
mains designated D1, D2, D3, D4, and D5 was expressed324 Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc.in insect cells using the baculovirus expression system.
Purified KIT ectodomain monomers or SCF-induced KIT
ectodomain homodimers (SCF-KIT 2:2 complex) were
each subjected to extensive screening for crystal growth
and optimization followed by determination of their crystal
structures (Experimental Procedures and Supplemental
Experimental Procedures available with this article online).
Structure of the KIT Ectodomain
KIT ectodomain shows an elongated serpentine shape
with approximate dimensions of 170 3 60 3 50 A˚
(Figure 1A). D1, D2, D3, D4, and D5 domains of KIT exhibit
a typical immunoglobulin super family (IgSF) fold, com-
posed of eight b strands, designated ABCC0DEFG, as-
sembled into a b sandwich consisting of two antiparallel
b sheets (Figure 1A). D1, D2, D3, and D5 each contain
a conserved disulfide bond connecting cysteine residues
at B5 and F5 (Fifth amino acids of strand B and F, respec-
tively), positions that bridge the two b sheets to form the
center of the hydrophobic core of the Ig-like fold (Harpaz
and Chothia, 1994). D2 and D5 contain two disulfide
bonds and D4 does not contain any cysteine residue; nev-
ertheless, the integrity of the Ig-like fold of D4 is main-
tained even though the conserved cysteine residues at
B5 and F5 are replaced by a valine and phenylalanine
residues, respectively.
The angle between D1 and D2 along the axis of the two
domains is 76 (Figures 1A and 1B), resembling the orien-
tation between the first and second Ig-like domains of the
interleukin-1b receptor (Vigers et al., 1997). In contrast, the
angle between D2 and D3 is 150, between D3 and D4 is
119, and between D4 and D5 is 162. The orientation
between the ABED and A0GFC b sheets for the different
Ig-like domains are 180 for D1-D2, 180 for D2-D3,
90 for D3-D4, and 180 for D4-D5 (Figure 1).
The superposition of all five Ig-like domains of KIT ecto-
domain with telokin (Holden et al., 1992) used as a stan-
dard for Ig-folds reveals root-mean-square deviations
(rmsd) of 1.5–2.9 A˚ for equivalent Ca atoms. D2 is the
most divergent among the five KIT Ig-like domains
(Figure S1) as revealed by its higher rmsd values when
superimposed with telokin. Based on structural conserva-
tion of key amino acids in Ig-like domains and their sec-
ondary structural topology (Harpaz and Chothia, 1994;
Halaby et al., 1999), D1, D2, D3, and D4 belong to the
I-subset and D5 is related to the C2 and IgCAM subsets
of IgSF (see Supplemental Data). Furthermore, among
the structurally conserved 20 finger-print residues of
IgSF (Harpaz and Chothia, 1994), 10–14 residues are con-
served in the five Ig-like domains of KIT (Table S1).
Inter Ig-like Domain Interactions in KIT
Monomeric Form
The interdomain interactions between the five Ig-like
domains of KIT are responsible for maintaining the overall
topology of KIT ectodomain monomers (Figure 1). The
orientation of D1 relative to D2 is determined by the ex-
tensive buried surface area that is caused by the numer-
ous interactions between the two Ig-like domains
(Figure 1B). The buried surface area of 1240 A˚2 in the
D1-D2 interface is much larger than the buried surface
areas of most inter Ig-like domain interfaces of rod-like
multidomain IgSF structures (Su et al., 1998) including
the three other inter Ig-like interfaces in the KIT ectodo-
main that range between 500 and 800 A˚2. This interface
is formed primarily by hydrophobic and electrostatic inter-
actions between strands A0 and G, loops EF and CC0 of D1
with the N-terminal region of strand A, the C-terminal end
of strand B, and loops BC and DE of D2 (Figure 1B and
Supplemental Data). Moreover, many residues in the D1-
D2 interface including amino acids from strands G of D1,
the linker region connecting D1 and D2, and the BC loop
of D2 are conserved in KIT from different species
(Figure 1B).
The buried surface area of the D2-D3 interface is
approximately 780 A˚2. The D2-D3 interface is composed
of a small hydrophobic patch surrounded by two electro-
static interactions. This interface is formed by interaction
between the EF loop of D2 and the DE loop of D3 and in-
teractions between the D2-D3 linker region and the FG
and BC loops of D3 (Figure 1C and Supplemental Data).
The buried surface area of the D3-D4 interface is approx-imately 570 A2. D3 and D4 interact primarily through
strands A0 and G of D3 with the BC and DE loops of D4
(Figure 1D and Supplemental Data). The length of the
D3-D4 interface is approximately 20 A˚ due to the angular
arrangement of D4 relative to D3 with an angle of 119
along the long axis of the two Ig-like domains. The D4-
D5 interface forms a buried surface area of 760 A˚2, mainly
mediated by hydrophobic interactions (Figure 1E). The in-
terface is formed by interactions between strands A, G,
and F of D4, with the BC and DE loops of D5, as well as
with the D4-D5 linker region (Figure 1E and Supplemental
Data).
Overall Structure of the SCF-KIT Complex
The structure of SCF-KIT complex shows 2:2 stoichiome-
try, in which two sets of 1:1 complexes in the asymmetric
unit are related by a noncrystallographic 2-fold symmetry
(Figure 2). The observed SCF-KIT 2:2 complex in the crys-
tal lattice is consistent with experiments demonstrating
that KIT dimerization is driven by the dimeric SCF ligand
(Philo et al., 1996; Lemmon et al., 1997). The two sets of
KIT ectodomains and SCF molecules resemble an upside
down ‘‘A’’ letter with approximate dimensions of 170 3
130 3 70 A˚ (Figure 2A and Figure S2).
The overall structure of SCF bound to KIT is similar to
the previously described structures of free SCF (Zhang
et al., 2000; Jiang et al., 2000). The structure of SCF-KIT
2:2 complex shows that an individual SCF protomer binds
directly to D1, D2, and D3 of an individual KIT protomer
(Figure 2B). Consequently, a single-receptor protomer
forms a symmetric complex with a similar 2-fold related
surface on an SCF protomer. Dimerization of KIT is also
mediated by homotypic interactions between the two
membrane-proximal Ig-like domains of KIT, namely by
D4-D4 and D5-D5 interactions (Figure 2B). This results in
dramatically altered configurations of D4 and D5 relative
to the rest of the molecule, and these configurations bring
the C termini within 15 A˚ of each other close to the place
where they connect to the transmembrane domain (Fig-
ures 2B and S2). The structure is also characterized by
the existence of a large cavity at the center of the complex
with dimensions of503 503 15 A˚ (Figure 2B). The crys-
tal structure demonstrates that each protomer of SCF
binds exclusively to a single KIT molecule and that recep-
tor dimerization is driven by SCF dimers that facilitate ad-
ditional receptor-receptor interactions.
SCF-Binding Region of KIT
SCF is bound to a concave surface formed by D1, D2, and
D3 of KIT in a configuration in which the four-helix bundle
of SCF is oriented perpendicularly to the long axis of D1,
D2, and D3 and the C termini of SCF and KIT are facing
opposite directions (Figures 2, 3, and S2). The solvent-
accessible surface area buried at the interface between
KIT and each SCF protomer is approximately 2060 A˚2,
a buried surface area that is within the range of known
ligand-receptor interfaces. It is possible to divide the
SCF-KIT interface into three binding sites (Figures 3ACell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc. 325
Figure 2. Crystal Structure of the SCF-KIT Ectodomain 2:2 Complex
(A) Ribbon diagram of the SCF-KIT 2:2 complex. Color coding of D1 to D5 is the same as in Figure 1 and SCF is colored in magenta. N and C termini of
KIT and SCF are labeled. Disulfide bonds in D1 and D5 are shown in ball-and-stick rendering with sulfur atoms colored in orange. Asparagine-linked
carbohydrates are represented in a stick model. Arrow marks a large cavity in the SCF-KIT 2:2 complex. (See stereo view in Figure S2.)
(B) Surface representations of the SCF-KIT ectodomain 2:2 complex. The figures show a top view (top), face view (center left), side view (center right),
and bottom view (low). Color coding is the same as in (A). The views show that a SCF dimer interacts symmetrically with D1, D2, and D3 of two
corresponding KIT ectodomains. In addition, KIT ectodomains form homophylic interactions through lateral contacts between D4 (orange) and
between D5 (pink) of two neighboring receptors.and 3B and Table S2). Site I is located in D1, site II is
located in D2 and in the D2-D3 linker region, and site III is
located in D3. The buried surface areas of sites I, II, and
III are approximately 280, 770, and 1010 A˚2, respectively.
Site I
The aC-b2 loop of SCF is aligned perpendicularly to strand
C0 of D1, as presented in Figure 3C. Asp72, Glu73, and
Thr74 of D1 and Lys990, Ser1010, and Phe1020 of SCF
are closely located at a Ca distance of 6–8 A˚, indicating
that these residues could participate in the interactions
between D1 and SCF. Due to poor side-chain electron
density of the aC-b2 loop, specific interactions could not
be defined.
Site II
SCF binding ismediated, for themost part, by complimen-
tary electrostatic interactions of charged surfaces on KIT
(Figures 3A, 3B, and 3D). Salt bridges are formed between
the basic amino acids Arg122, Arg181, Lys203,
and Arg205 of KIT with the acidic amino acids Asp540,
Asp770, Asp840, and Glu880 on SCF. The conformation of
Arg122 is stabilized by the salt bridge between Glu198
of KIT and Asp540 of SCF. Figure 3D shows that three of326 Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc.the major interacting residues, Tyr125, Arg181, and
Lys203, on D2 are aligned on the same plane and form
hydrogen bonds with Asp770, Asn810, Asp840, Ser530,
and Thr570 of aB and aC of SCF. The van-der-Waals
contacts between Ser123 and Ile201 of D2 and Val500
and Thr570 of SCF also contribute to the formation of a
ligand-receptor complex. However, there are notable dif-
ferences in residues of site II in KIT and SCF from other
species (Figures 3, S1, and S3). While Arg181 and
Lys203 are invariant as basic amino acids in mammals,
Tyr125 is substituted by a phenylalanine in mouse and
rat, which most likely results in loss of a hydrogen bond.
Arg205 of KIT is a highly conserved amino acid while
Glu880 is substituted for by leucine and alanine residues
in mouse and rat, respectively. Furthermore, Arg122 of
KIT and Asp540 of SCF in human are substituted by a leu-
cine or valine inmouse and rat, respectively. These substi-
tutions may account for the reduced affinity of rodent SCF
toward human KIT (Lev et al., 1992).
Site III
The N-terminal segment of SCF interacts with strand D of
D3 (Figures 3A and 3E). Hydrogen bonds are formed be-
tween the side chain of Asn100 of SCF and the main-chain
Figure 3. SCF Recognition by KIT
(A) Views of the SCF-KIT interface. Amino acids in the buried surfaces in SCF and KIT ectodomain are visualized by pulling apart the two molecules.
The figure shows the molecular surface of KIT D1-D2-D3 (left) and SCF (right). Acidic amino acids are shown in red, basic amino acids in blue, polar
amino acids in orange, and hydrophobic amino acids in yellow. SCF binding site I, site II, and site III on KIT are circled.
(B) Complementarity in electrostatic potential in the ligand-receptor interface. The right panel shows a view following a rotation of 180 along the
vertical axis of the electrostatic surface presented in the left panel. Electrostatic surface potential of D1-D2-D3 superimposed on the molecular
surfaces with an imprint of a cartoon diagram of bound SCF that is colored in green is shown. Right panel depicts the electrostatic surface potential
of SCF-bound KIT colored in blue (positive) and red (negative). KIT is shown in a form of ribbon diagram colored in cyan.
(C–E) Close-up views of site I (C), site II (D), and site III (E) of the SCF-KIT interface. SCF is colored in green and KIT in cyan. Interacting amino acids are
labeled, hydrogen bonds are drawn as dashed yellow lines, and secondary structure elements are marked on the ribbons and strands.amide and carbonyl group of Ser261, as well as with the
side chain of Asp260 and Trp262 on D3. In addition,
Thr90 and Asn110of SCF bind to the side-chain and
main-chain amides of Ser261 and His263 of KIT, respec-
tively. Mutational analysis of SCF has shown that replace-
ment of Asn100 with alanine or glutamic-acid residues
reduces the binding affinity of SCF toward KIT by approx-
imately 10-fold and that Asn100 (or Asp in other species) is
necessary for biological activity (Hsu et al., 1998). Com-
parison of the receptor-binding interface in SCF from
different species shows that Asn100 (or Asp) is a highly
conserved residue (Figure S1). Additional important
interactions are mediated by Asn60 and Arg70 of SCF via
van-der-Waals contacts with Tyr259, Thr269, Ser240,
Val242, Ser241, and Ser244 on D3 of KIT.
The Ligand-Binding Domain of KIT Is Poised
for SCF Binding
Superimposition of the structures of individual D1, D2, and
D3 of KIT monomeric form with corresponding structuresof the SCF-induced homodimeric form reveals rmsd
values of 0.5, 0.8, and 1.1 A˚ for 82, 92, and 100 aligned
Ca residues in D1, D2, and D3, respectively. Similarly,
superimposition of the structure of the entire D1-D2-D3
region of KITmonomers with the corresponding structures
in the SCF-KIT 2:2 complex reveals an rmsd of 1.1 A˚ for
274 aligned Ca residues of the D1-D2-D3 region. Remark-
ably, there are no significant backbone changes in the
structures of the SCF-binding pocket of KIT (Figures 3
and S4). However, several minor structural changes
were detected in the SCF-binding cleft upon SCF binding.
A structural change is seen in the top half of strands G, F,
and C (amino acids 167–187 and 143–166) of D2 following
SCF binding (Figures 1A and 2A). These strands are
located at the side opposite to the SCF-binding interface
and are not involved in mediating any direct contacts
with SCF. Overall, comparison of the structures of KIT
monomers to those of SCF-occupied KIT dimers show
that the D1-D2-D3 region of KIT may be viewed as a
functional unit that is poised for SCF binding followed byCell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc. 327
subsequent KIT dimerization driven by dimeric SCF
molecules.
Conformational Changes in SCF Molecules
Bound to KIT
While the overall structure of SCF bound to KIT is similar to
the structure of free SCF, there are notable differences in
the angle between the two protomers, in the conforma-
tions of the connecting loops, and in the structures of
the flexible N terminus of themolecule (Figure 4). Compar-
ison of the published structures of SCF dimers (entries
1EXZ and 1SCF in the Protein Data Bank [PDB]) shows
that the angle between the two protomers (the angles
between aC helices) of free SCF homodimers may vary
by 2 to 6 in the different structures, suggesting that a cer-
tain degree of flexibility exists in the SCF dimer. The range
of differences in the angles between KIT-bound SCF
protomers to those of free SCF was increased by 3–9.
Figure 4 shows a KIT-bound SCF structure in which the
angle between SCF protomers is increased by 5. Inter-
estingly, it was shown that the flexibility of the cytokine
activin plays a role in the assembly of TGF-b receptors
(Greenwald et al., 2004).
Figure 4. Conformational Changes in SCF upon Binding to
KIT
(A) The angle between the two SCF protomers is altered upon KIT bind-
ing. The view shows a cartoon diagram of free SCF (green) (Zhang
et al., 2000) and SCF bound to KIT (magenta). Superimposition of
the one SCF protomer (left) reveals an angular movement of approxi-
mately 5 of the second protomer (right), as measured for helix aC.
Helices are labeled and shown as cylinders.
(B) Conformational change in the N terminus of SCF upon KIT binding.
Site III of KIT is shown as amolecular surface (gray), and the N terminus
of free SCF is shown in green and of SCF bound to KIT in magenta.
Disulfide bond between Cys40 and Cys890 is shown as a yellow stick.
Key amino acids are labeled and shown as a stick model.
(C) Conformational change in aC-b2 loop of SCF upon binding to site I
of KIT. Color coding is the same as in (B).328 Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc.Figure 4B shows that the N terminus of free SCF from
Cys40 to Asn110 has a random-coil configuration (Zhang
et al., 2000). It was also shown that deletion of the first
four amino acids leads to approximately 25% reduction
in the binding affinity of SCF to KIT, suggesting that the
disulfide bridge between Cys40 and Cys890 plays a role
in maintaining the functional integrity of SCF (Langley
et al., 1994). Figure 4B also shows that Thr90 and Asn100
of the N terminus region of SCF bound to KIT undergo
a conformational change in which their Ca positions
become displaced by 3 to 5 A˚ upon receptor binding
(Figure 4B). The disulfide bridge between Cys40 at the
N terminus and Cys890 at the aC helix appears to play
an important role in mediating the conformational change
that takes place in the N terminus of SCF. The position of
Cys240 in free SCF is not altered upon receptor occupancy
as revealed by an rmsd of 1.2 A˚ of Ca positions. Finally,
The aC-b2 loop of free SCF is either disordered or has
a different structure from the structure of the aC-b2 loop
in SCF bound to KIT. Figure 4C shows that the aC-b2
loop of SCF undergoes a large conformational change
upon receptor binding, a change critical for establishment
of site I of the SCF-KIT interface.
A Large Rearrangement in D4 and D5 Orientations
in SCF-Bound KIT
Superimposition of the structures of individual D1, D2, D3,
D4, and D5 of KIT monomeric form with corresponding
individual Ig-like domains in the SCF-induced homodi-
meric form reveals minor changes in the structure of KIT
Ig-like domains following SCF binding. By contrast, super-
imposition of the D3-D4-D5 region of KIT monomeric form
with the corresponding region in the homodimeric form
reveals a large structural change in the orientation of D4
and D5 relative to each other and relative to the ligand-
binding region of KIT (Figures 5A and S5). Each of the
individual domains D3, D4, and D5 of monomeric KIT
can be superimposed with their counterparts in the SCF-
occupied KIT with rmsd values of 0.9, 0.9, and 1.9 A˚ for
98, 101, and 85 Ca atoms of D3, D4, and D5, respectively.
However, superimposition of D3 structure of KIT mono-
mers with D3 structure in ligand-occupied homodimeric
form reveals a dramatic movement in the orientation of
D4 and D5 in SCF-bound KIT (Figure 5A). The reorienta-
tions of D4 and D5 relative to the ligand-binding region
occurs by a rotation along an axis in the linker connecting
D3 to D4 and a rotation along an axis in the linker connect-
ing D4 to D5 running through the D3-D4 and D4-D5 inter-
faces (Figure 5A), respectively. Comparison of the free and
ligand-bound KIT shows that D4 of ligand-occupied KIT
rotates relative to D3 by 22, and D5 of ligand-occupied
KIT rotates relative to D4 by 27 (Figure 5A). The rear-
rangements of D4 and D5 in SCF-occupied KIT result in
receptor-receptor interactions that are mediated by D4-
D4 and D5-D5 interactions of two neighboring KIT
molecules (Figure 5B). The conformation of the DE loop
of D5 is altered in SCF-occupied ectodomain.
Reorientation of D4 and D5 driven by receptor dimeriza-
tion imposes upon the DE loop of D5 a new configuration
(Figure 5A).
D4:D4 Interactions in KIT Homodimers
Homotypic interactions between D4 of two neighboring
KIT molecules are mediated by the D4-D4 interface in
the SCF-KIT 2:2 complex. The D4-D4 interface is medi-
ated by two b sheets formed by the ABED strands of D4
of each KIT protomer to form a nearly planar arrangement
in which Arg381 of each protomer points toward each
other resulting in a buried surface area of 360 A2. Figure 6A
shows that Arg381 and Glu386 form salt bridges and van-
der-Waals contacts across the 2-fold axis of the KIT
Figure 5. Reconfiguration of KIT D4 and D5 upon SCFBinding
(A) Reconfiguration of D4 and D5 in the SCF-KIT complex. Superimpo-
sition of D3 from the KIT monomer with D3 of KIT bound to SCF (both
colored blue) shows that D4 of the bound form (red) moves by 22 rel-
ative to the position of D4 of the free form (green). Superimposition
(right panel) of D4 of the two forms (both in blue) shows that D5 of
the SCF-bound form (red) moves by 27 relative to the positions of
D5 of the free form (green). The two bottom panels show close views
of the hinge regions of the D3-D4 and D4-D5 interfaces of the mono-
meric (green) and homodimeric (red) forms.
(B) Surface representation of D4 and D5 of SCF-occupied KIT (top
panel), viewed in the same orientation as in Figure 2. The black outline
shows the location of D4 andD5 of KIT ectodomainmonomers bridged
by SCF binding to the ligand-binding region. Reconfiguration of D4 and
D5 leads to a movement of the C termini of two neighboring ectodo-
mains from 75 A˚ to 15 A˚ from each other. Lower panel shows a view
from the cell membrane (bottom view) of the SCF-KIT complex (see
Movies S1 and S2). Note a 90 rotation along the x axis. Color coding
of D1 to D5 is the same as in Figure 1.dimer. In addition, the side chains of Arg381 of each pro-
tomer form hydrogen bonds with the main-chain carbonyl
of the corresponding residue of the neighboring KIT mol-
ecules.
Structure-based sequence analysis has shown that the
D4-D4 interface is conserved in most type III RTKs includ-
ing CSF1R, PDGFRa, and PDGFRb (Figures 6B and S1). In
PDGFRaGlu386 is replaced by an aspartic acid, a residue
that could also function as a salt bridge partner. A pair of
basic (Arg381) and acidic (Glu386) residues are strictly
conserved in type III RTKs of different species. The se-
quence motif found in the D4-D4 interface is also con-
served in the membrane-proximal 7th Ig-like domain (D7)
of all members of type V RTKs (VEGFR family) including
FLT1 (type 1), FLK1 (type 2), and FLT4 (type 3). In VEGFR,
the basic (Arg) and acidic (Asp) residues are located in the
EF loop. Although the core sequence motif that is respon-
sible for the D4-D4 interface is located in a different Ig-like
domain of VEGFR (i.e., D7 versus D4) it is possible that re-
ceptor-receptor interactions similar to those seen in the
D4-D4 interface of KITwill also take place through a similar
D7-D7 interface (Figure 6A) in all members of the VEGFR
family of RTKs (Ruch et al., 2007).
D5-D5 Interactions in KIT Homodimers
Figures 2B, 5B, and 6C show that in the SCF-KIT 2:2
complex neighboring D5 protomers are parallel and in
a close proximity to each other as well as in an orientation
likely to be perpendicular to the cell membrane. The
b sheet topology of D5 follows an atypical arrangement
that is different from most I-set IgSF in which strand A is
split into strand A and A0 (see also Supplemental Data).
Strand A of D5 is paired with strand B resulting in the
b sheet topology of ABED/CFG. Consequently, strands
A and G that are located at the edge of two b sheets
(ABED/CFG) are nearly parallel at a distance of 6.5–
11.5 A˚ in the Ca from each other. Moreover, strands A
and G of one protomer face strands A and G of neighbor-
ing D5 in a 2-fold symmetry. The side chains of Asn505 of
two neighboring KIT protomers are approximately 4.2 A˚
from each other, but water or metal ions that may mediate
indirect interactions between the two asparagines could
not be detected in this area of weak electron density. Ad-
ditional D5-D5 interactions are mediated by Tyr418 of two
neighboring KITmolecules (Figure 6C). The interaction be-
tween hydroxyl groups of neighboring Tyr418 side chains
could be mediated by water molecules. It also suggests
that the relative positions of neighboring D5 domains are
mediated by indirect interactions formed by Tyr418 and
Asn505 of the neighboring protomers. The G strand of
D5 is connected via a short linker to the transmembrane
domain of KIT.
KIT Mutations in Human Diseases
Avariety of humandiseases are causedbymutations in the
KIT gene. In humans, loss-of-function mutations in the ec-
todomain of KIT cause the piebald trait (Fleischman et al.,
1996; Murakami et al., 2005). These exon 2 and exon 3Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc. 329
Figure 6. Views of the D4-D4 and D5-D5
Interfaces
(A) 2Fo-Fc electron density map contoured at
1.1s level showing a view of the D4-D4 inter-
face (top panel). The backbones of KIT proto-
mers are represented as pink and yellow tubes,
respectively. A close view (bottom panel) of the
D4-D4 interface of two neighboring ectodo-
mains is shown. Interchain hydrogren bonds
formed between Arg381 and Glu386 of two
adjacent D4 are colored in yellow. Key amino
acids are labeled and shown as a stick model.
Secondary structure elements are labeled
according to the IgSF nomenclature.
(B) Conservation of the D4-D4 dimerization
motif across members of type III and type
V RTK families. Residues 370–398 of human
KIT (AAC50969.1) aligned with sequences
of (with accession numbers) mouse
(AAH75716.1), chicken (NP_989692.1), Xeno-
pus laevis (AAH61947), salamander
(AAS91161.1), and zebrafish (type A and B
(NP_571128, XP_691901) homologs. Also
shown are amino-acid sequences of CSF1R
from human (P07333), mouse (P09581), and
torafugu type A and B (P79750, Q8UVR8) and
sequences from PDGFRa and PDGFRb from
human (P16234, P09619) and mouse
(NP_035188, P05622). Amino-acid sequences
of type V RTKs of human VEGFR type 1–3
(7th Ig-like domain) (P17948, P35968, and
P35916) are also presented. Secondary struc-
ture elements on KIT are labeled on the top of
the sequence alignment. The conserved resi-
dues of Arg381 and Lys383, Leu382 and
Leu379, and Glu386 and Gly388 are colored
in blue, yellow, red, and green, respectively.
(C) Ribbon diagram of a D5-D5 interface. Strands A and G of two adjacent KIT protomers participate in formation of the D5-D5 interface. The D5-D5
interface is maintained by lateral interactions between Tyr418 and Asn505 of two neighboring receptors probably through ion(s) or water molecule(s).
(D) Electrostatic potential surfaces of D4 and D5 of KIT. The figures show a face view of the D4-D4 interacting surface (right) and a view following 90
rotation along the vertical axis (left). The position of acidic patch and the D4-D4 interfaces are circled and the interacting residue Arg381 and Glu386
are labeled.point mutations in the KIT locus result in Cys136 being
replaced by an arginine residue and Ala178 being
substituted for by a threonine residue. Both mutations
take place in D2, a critical component of the SCF-binding
site on KIT (Figure 7A). The piebald Cys136Arg mutation
will cause the loss of an important disulfide bond that
plays a critical role in maintaining the structural and func-
tional integrity of D2 and hence its capacity to recognize
SCF. Ala178 is located in the EF loop of D2 in close prox-
imity to the D2-D3 interface (Figure 7A). The piebald
Ala178Thr mutation may disrupt interactions that are es-
sential for maintaining the integrity of the D2-D3 interface
and interactions that are required for D2 and/or D3 binding
to SCF (Figure 7A).
A variety of gain-of-function mutations in the KIT locus
were found in different cancers including GIST, AML,
and SCLC (reviewed in Forbes et al., 2006). Many onco-
genic mutations were identified in the JM and in the PTK
domains of KIT. A variety of oncogenic mutations were330 Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc.also found in KIT ectodomain (Figure 7A) including in-
frame deletions, point mutations, in-frame duplications,
and insertions that collectively lead to formation of acti-
vated forms of KIT. In-frame deletion and insertional muta-
tions at exon 8 involving either a loss or substitution of
Asp419 were described in patients with AML, while dupli-
cations of Ala502-Tyr503 and Ala502-Phe506 sequences
were identified in GIST (Figure 7A). Asp419 is located in
a region connecting strand A and the AB loop of D5, and
Ala502-Tyr503 are located on strand G of D5 of KIT. Inter-
estingly, virtually all the activating oncogenic mutations
that were found in KIT ectodomain were mapped to the
D5-D5 interface (Figure 7A). Themost plausible interpreta-
tion of themode of action of the oncogenic D5mutations is
that these mutations enhance the binding affinity and ho-
motypic interactions between neighboring D5 domains by
increasing the on-rate or decreasing the off-rate or altering
the rates of both processes in a fashion that facilitates en-
hanced D5-D5 interactions.
Figure 7. KIT Ectodomain Mutations Im-
plicated in Cancer and Other Diseases
and Mechanism of KIT and Other RTK
Activation
(A) Loss-of-function mutations responsible for
the piebald trait (left panel). A ribbon diagram
of D1 (blue), D2 (green), and D3 (yellow) and
a surface representation of SCF (gray) are
shown. Mutated amino acids are colored in
red. Gain-of-function mutations responsible
for GIST, SCLC, and AML are shown (right
panel). Surface representation of D4 and D5
in the homodimeric form is colored in gray.
Ala502 and Tyr503 that are duplicated in GIST
are shown in blue and deletions and insertional
mutations in proximity to Asp419 (AML and
NCLL) are shown in green. Note that the acti-
vating KIT mutations are confined to the D5-
D5 interface.
(B) KIT activation is compromised by point
mutants in D4-D4 interface. HEK293 cells tran-
siently expressing wild-type KIT (WT), R381A,
or E386A point mutations in D4were stimulated
with 10 ng/ml SCF for 6 min at 37C as indi-
cated (upper left panel). Lysates of unstimu-
lated or SCF-stimulated cells were subjected
to immunoprecipitation (IP) with anti-KIT anti-
bodies followed by SDS-PAGE and immuno-
blotting (IB) with either anti-KIT or anti-phos-
photyrosine (p-Tyr) antibodies. Densitometric
quantitation of tyrosine autophosphorylation
of KIT from anti-p-Tyr immunoblots (upper
right panel). 3T3 cells stably expressing wild-
type KIT (WT) or the R381A mutant were
treated with different concentrations of SCF.
Lysates from unstimulated or SCF-stimulated
cells were subjected to immunoprecipitation
with anti-KIT antibodies followed by SDS-
PAGE and immunoblotting with anti-KIT or
anti-p-Tyr antibodies (lower left panel). Displacement assay of cell-bound 125I-SCF using native SCF. 3T3 cells expressing WT (-), R381A (;),
R381A/E386A (A), or a kinase-negative KIT (:) were treated with 125I-SCF in the presence of increasing concentrations of native SCF. The EC50
(ligand concentration that displaces 50% of 125I-SCF bound to c-KIT) of SCF toward WT KIT (1.1 nM) is comparable to the EC50 of SCF toward
R381A (1.0 nM), R381A/E386A (0.8 nM), or the kinase-negative KIT mutant (1.4 nM).
(C) Models for KIT and other RTK activation driven by soluble (left panel) or membrane-anchored (right panel) SCF molecules expressed on the cell
surface of a neighboring cell. SCF binding to the D1-D2-D3 ligand-binding module brings the C termini of the two bound KIT ectodomain monomers
within 75 A˚ of each other. We propose that the flexibility of the D3-D4 and D4-D5 hinges enables lateral D4-D4 and D5-D5 interactions that bring the C
termini of two neighboring ectodomains within 15 A˚ of each other. Consequently, the increased proximity and local concentration of KIT cytoplasmic
domains leads to autophosphorylation of regulatory tyrosine residues in the kinase domain resulting in PTK activation. (Note that PTK activation is not
drawn in the model.) Recruitment and activation of a complement of cell-signaling molecules will proceed following phosphorylation of key tyrosines
in the cytoplasmic domain. The model is based on free SCF structure, ligand-free KIT, SCF-KIT complex, and KIT PTK structure (PDB entries 1QZJ,
1R01, and 1T45). Regions whose structures have not been determined were modeled using secondary structure prediction (green helices and black
loops). SCF is colored in magenta, KIT ectodomain in blue, and KIT PTK in light blue.Mechanism of Receptor Activation
The structures of KIT ectodomain monomers and SCF-in-
duced dimers provide novel insights concerning the
mechanism of ligand-induced activation of KIT and other
RTKs containing five or seven Ig-like domains in their
extracellular domains. Comparison of the structures of
D1, D2, and D3 of KIT ectodomain monomers to the cor-
responding region in the SCF-induced ectodomain dimers
shows very few structural alterations in the SCF-binding
pocket and in other parts of D1, D2, and D3 followingSCF binding. On the basis of their distinct biochemical
functions, we have divided the ectodomain of KIT into
three independent functional units. The first unit is com-
posed of the three membrane-distal Ig-like domains D1,
D2, andD3. The D1-D2-D3 region acts as a separatemod-
ule that functions as a specific SCF binding unit. The SCF-
binding unit is connected by a flexible joint (D3-D4 inter-
face) to D4, a second independent unit that is connected
by an additional flexible joint (D4-D5 interface) to D5,
defined as a third independent unit. The function of D4Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc. 331
and D5 is to mediate, respectively, lateral D4-D4 and D5-
D5 interactions that bring together and stabilize interac-
tions between the membrane-proximal region of two
neighboring KIT ectodomains.
According to this view, dimerization of KIT is driven by
bivalent SCF binding whose sole function is to bind SCF
and to bring together two KIT molecules. SCF-induced
KIT dimerization is followed by a large change in D4 and
D5 orientations relative to the position of the D1-D2-D3
SCF-binding unit. We propose that the flexible joints at
the D3-D4 and D4-D5 interfaces enable lateral interac-
tions that result in a large conformational change upon
receptor dimerization. Rather than inducing a conforma-
tional change in KIT, dimerization may select particular
conformations in a transition from a flexibly jointed mono-
mer to a rigid dimer. This culminates in complex forma-
tions between two neighboring D4 and two neighboring
D5 of KIT, bringing the C termini of D5 to a point at the
cell membrane in which the transmembrane domains of
two neighboring KIT molecules are within 15 A˚ of each
other. Indeed, SCF-induced tyrosine autophosphorylation
of KIT (Figure 7B) and stimulation of a downstream signal-
ing pathways (data not shown) are strongly compromised
by a point mutation in either Arg381 or Glu386 within D4 of
KIT. PDGF-receptor activation and stimulation of down-
stream signaling pathways are also compromised by sim-
ilar point mutations in D4 of PDGFR (Y.Y. and S.Y., unpub-
lished data). We propose that the homotypic interactions
between membrane-proximal regions of KIT are mediated
primarily by the D4-D4 interface and that the D5-D5 inter-
face plays a cooperative secondary role by facilitating
exact positioning of two KIT ectodomains at the cell-
surface interface.
The SCF-KIT complex exhibits strong polarization of the
electrostatic field with the following characteristics: (1) an
overall negatively charged surface; (2) complementarity
between SCF (negative) and the ligand-binding D1-D2-
D3 unit (positive); and (3) a strongly negatively polarized
surface right above and around the D4-D4 interface (Fig-
ures 6D, 3B, and S6). We propose that the binding of
SCF to KIT occurs in at least two steps: First, the electro-
static attraction between SCF and D1-D2-D3 will align
SCF along the opposing ligand-binding region on KIT.
The electrostatic attraction may also lead to a faster asso-
ciation rate of SCF due to a steering effect (Mueller et al.,
2002). Subsequently, SCF-KIT complex formation will be
stabilized by additional interactions including those medi-
ated by a conformational change in bound SCF mole-
cules. The strongly polarized electrostatic surface on D4
may also play a role in maintaining KIT in a monomeric
inactive configuration by inducing repulsion between D4
domains of neighboring KIT receptors (Figure 6D). The
binding affinities of D4 toward D4 and D5 toward D5 of
neighboring receptors are probably too low to facilitate
KIT ectodomain dimerization before the local receptor
concentration on the cell surface is increased by SCF-
driven receptor dimerization and by the effect of dimen-
sionality. Once such a threshold of local concentration is332 Cell 130, 323–334, July 27, 2007 ª2007 Elsevier Inc.reached, the attraction between neighboring D4 will over-
come the electrostatic repulsion to the extent that two
neighboring D4 units will be able to bind to each other.
Interestingly, the main interactions that maintain the D4-
D4 interface, i.e., double salt bridges between Arg381
and Glu386 in a neighboring KIT molecule are also medi-
ated by electrostatic interactions.
The ectodomains of KIT and C-cadherin (Boggon et al.,
2002) are each composed of five tandem Ig-like domains
and both exhibit a similar elongated topology: 170 A˚ for
KIT and 185 A˚ for C-cadherin. Moreover, the bacterial
adhesion molecule invasin exhibits a remarkably similar
elongated architecture and inter-Ig-like domain topolo-
gies (Hamburger et al., 1999). KIT ectodomains may
have evolved from a common ancestral gene that coded
for a protein that mediates cell-cell interactions. While
classical cadherins utilize their most membrane-distal
Ig-like domains for homotypic binding that mediates
cell-cell interactions, the ectodomain of KIT has evolved
to function as a cell-signaling receptor that binds mem-
brane-anchored or soluble SCF isoforms to induce recep-
tor dimerization and activation (Figure 7C).
Since the hallmarks of KIT structure, ligand binding, and
receptor dimerization are conserved in other receptors,
the mechanism described in this report for KIT activation
may be a general mechanism for activation of many
receptors (Figure 7C).Moreover, the structural information
described in this report could be applied to design novel
therapeutic interventions for treatment of cancers and
other diseases driven by activated receptors.
EXPERIMENTAL PROCEDURES
Protein Expressions and Purifications
A soluble KIT ectodomain (amino acids 1–519) containing a polyhisti-
dine tag at the C terminus was expressed in insect cells (Sf9) using
the baculovirus expression system. KIT ectodomain was purified by
Ni-chelate followed by size-exclusion chromatography (Superdex
200, GE Healthcare). After partial deglycosylation using endo-glycosi-
dase F1, the ectodomain was further purified by anion exchange chro-
matography (MonoQ, GE Healthcare). SCF (1–141) was expressed,
refolded, and purified as previously described (Langley et al., 1994;
Zhang et al., 2000). Full details are described in Supplemental Exper-
imental Procedures.
Crystallizations and Data Collections
Samples of KIT ectodomain alone or in complex with SCF were sub-
jected to extensive screening for crystal growth and optimization.
Crystals of deglycosylated ectodomain of approximate dimensions
of 0.123 0.13 0.05 mmwere obtained in phosphate buffer with poly-
ethyleneglycol (PEG) as the precipitant (0.1 M Na-Pi buffer pH 6.0,
0.2 M KCl, 12% PEG 400) at 4C. All crystals were immersed in a res-
ervoir solution supplemented with 5%–18% glycerol for several sec-
onds, flash cooled, and kept in a stream of nitrogen gas at 100 K during
data collection. The crystals belonged to the rhomboidal space group
R3 with unit cell dimensions of a = 162.4 A˚, and c = 67.1 A˚ in hexagonal
lattice setting, with one molecule per asymmetric unit. Platinum,
bromine, and iodine derivatives of KIT were prepared by soaking the
crystals in a reservoir solution containing heavy atom reagents in
concentration ranges of 0.1 mM to 50 mM at 277 K for a few seconds
to 10 days.
Crystals of the SCF-KIT complex were grown with PEG as the pre-
cipitant (0.2 M ammonium sulfate, 8%–12% PEG 8000, 5%–8% ethyl-
ene glycol at pH 7.0–8.5) at 4C and diffraction data were collected to
a resolution of 3.5 A˚ with a ADSD quantum-210 CCD detector at the
X25 beamline of NSLS, Brookhaven National Laboratory. The crystals
belong to the monoclinic space groupC2, with unit cell dimensions a =
269.5 A˚, b = 52.1 A˚, c = 189.8 A˚, b = 108.2, which is comprised of two
sets of SCF and KIT molecules in the asymmetric unit. All data sets
were processed and scaled using the DENZO and SCALEPACK and
the HKL2000 program package (Otwinowski and Minor, 1997). The
data collection statistics are summarized in Table S3A.
Structure Determination
The experimental phases were calculated by using multiple isomor-
phous replacement with anomalous scattering (MIRAS) and by multi-
wavelength anomalous diffraction (MAD) to 3.0 A˚ resolution (Table
S3A). The resulting electron-density maps showed continuous elec-
tron density of b sandwich structures and clear solvent-protein bound-
aries. The molecular model of monomeric KIT ectodomain was built
manually into the experimental electron density maps. The structure
was refined to 3.0 A˚ resolution using the native data set to a crystallo-
graphic R factor of 25.4% and free R factor of 29.6% (Table S3B). The
structure of the SCF-KIT 2:2 complex was solved by molecular re-
placement using the structure of the monomeric form described in
this report and the structure of SCF (Zhang et al., 2000; PDB code:
1EXZ) as search models. The structure was refined to 3.5 A˚ resolution
using the native data set to a crystallographic R factor of 24.9% and
free R factor of 29.5% (Tables S3A and S3B). Full details are described
in Supplemental Experimental Procedures.
Molecular Graphics
Molecular images were produced using Pymol (http://pymol.
sourceforge.net/) and CCP4MG (Potterton et al., 2004) software.
Cell Lines and Expression Vectors
Full details are described in Supplemental Experimental Procedures.
Supplemental Data
Supplemental Data include Experimental Procedures, six figures, and
twomovies and can be found with this article online at http://www.cell.
com/cgi/content/full/130/2/323/DC1/.
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The atomic coordinates and structure factors of KIT monomer and
SCF-KIT complex have been deposited in the Protein Data Bank
(http://www.rcsb.org/pdb) with accession codes 2EC8 and 2E9W,
respectively.
